tiprankstipranks
Trending News
More News >
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Income Statement

Compare
346 Followers

Evaxion Biotech Income Statement

Last quarter (Q3 2024), Evaxion Biotech's total revenue was $3.03M, an increase of Infinity% from the same quarter last year. In Q3, Evaxion Biotech's net income was $-1.94M. See Evaxion Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.34M$ 73.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.34M$ 72.89K$ -571.32K$ -343.45K$ -105.72K
Operating Expenses
$ 18.08M$ 22.25M$ 25.26M$ 25.83M$ 16.57M
Depreciation and Amortization
$ 607.02K$ 615.95K$ 571.32K$ 343.45K$ 105.72K
EBITDA
$ -9.77M$ -21.40M$ -22.58M$ -24.17M$ -16.46M
Operating Income
$ -14.73M$ -22.20M$ -25.26M$ -25.83M$ -16.57M
Other Income/Expenses
$ 3.38M$ -718.00K$ 1.32M$ 1.12M$ -7.00K
Pretax Income
$ -11.36M$ -22.91M$ -23.94M$ -24.71M$ -16.57M
Net Income
$ -10.57M$ -22.13M$ -23.17M$ -24.53M$ -15.02M
Per Share Metrics
Basic EPS
$ -10.00$ -32.44$ -39.20$ -50.32$ -37.08
Diluted EPS
$ -10.00$ -32.44$ -39.20$ -50.32$ -37.08
Weighted Average Shares Outstanding
1.07M 683.39K 590.97K 487.33K 404.97K
Weighted Average Shares Outstanding (Diluted)
1.07M 683.39K 590.97K 487.33K 404.97K
Currency in USD

Evaxion Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis